Demand for Indian generic drugs skyrockets in China amid Covid surge
Beijing : The demand for Indian generic drugs has shot up in China amid the massive COVID surge in the country, with Chinese experts cautioning that fake versions of these drugs are flooding the market.
China’s National Health Security Administration said on Sunday that Pfizer’s Paxlovid oral medication, which is used to treat Covid-19, could not be included in the “register of drugs in the basic medical insurance”, because the company’s quotation was too high, media reports here said.
Due to the massive short supply of Paxlovid, demand for Indian generic versions has gone up through Chinese e-commerce platforms.
Must Read
- Covid-19 Drugs : South Korea to supply generic drugs for…
- WHO chief warns about spike in COVID-19 as cases surge in…
- Covid Alert : China witnesses surge in COVID cases, more…
- Ban political Rallies: Amid COVID-19 surge, Punjab Health…
- India's jet fuel demand faces rough patch amid third wave…
- Japan conveys concerns to China, Russia about joint…
- Apple will increase production in India, Southeast Asia,…
- Health Ministry writes to states, UT over surge in COVID-19…
- PM Modi stresses on 'test, track and treat' with same…
- COVID-19: Maharashtra on Alert amid rising cases in China,…